Works matching AU Solomon, Scott

Results: 518
    1

    A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).

    Published in:
    2019
    By:
    • McMurray, John J.V.;
    • DeMets, David L.;
    • Inzucchi, Silvio E.;
    • Køber, Lars;
    • Kosiborod, Mikhail N.;
    • Langkilde, Anna M.;
    • Martinez, Felipe A.;
    • Bengtsson, Olof;
    • Ponikowski, Piotr;
    • Sabatine, Marc S.;
    • Sjöstrand, Mikaela;
    • Solomon, Scott D.;
    • McMurray, John JV;
    • DeMets, David L;
    • Inzucchi, Silvio E;
    • Kosiborod, Mikhail N;
    • Langkilde, Anna Maria;
    • Martinez, Felipe A;
    • Sabatine, Marc S;
    • Solomon, Scott D
    Publication type:
    journal article
    2

    Race and Ethnicity in Heart Failure Trials: Time to Update Recommended Categories for Global Relevance.

    Published in:
    Journal of the American Heart Association, 2025, v. 14, n. 12, p. 1, doi. 10.1161/JAHA.124.037810
    By:
    • Mingming Yang;
    • Toru Kondo;
    • Dewan, Pooja;
    • Desai, Akshay S.;
    • Sibulo Jr., Antonio S.;
    • Lam, Carolyn S. P.;
    • Chern-En Chiang;
    • Gomez, Efrain A.;
    • Martinez, Felipe A.;
    • Thierer, Jorge;
    • Nicolau, Jose C.;
    • Kerr Saraiva, Jose F.;
    • Masafumi Kitakaze;
    • Packer, Milton;
    • Vaduganathan, Muthiah;
    • Pham Nguyen Vinh;
    • Abraham, William T;
    • Jhund, Pardeep S.;
    • Solomon, Scott D.;
    • McMurray, John J. V.
    Publication type:
    Article
    3
    4
    5

    Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration.

    Published in:
    Journal of Diabetes Research, 2018, p. 1, doi. 10.1155/2018/1631263
    By:
    • Seferovic, Jelena P.;
    • Bentley-Lewis, Rhonda;
    • Claggett, Brian;
    • Diaz, Rafael;
    • Gerstein, Hertzel C.;
    • Køber, Lars V.;
    • Lawson, Francesca C.;
    • Lewis, Eldrin F.;
    • Maggioni, Aldo P.;
    • McMurray, John J. V.;
    • Probstfield, Jeffrey L.;
    • Riddle, Matthew C.;
    • Solomon, Scott D.;
    • Tardif, Jean-Claude;
    • Pfeffer, Marc A.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren.

    Published in:
    European Journal of Heart Failure, 2012, v. 14, n. 2, p. 185, doi. 10.1093/eurjhf/hfr125
    By:
    • Shah, Amil M.;
    • Shin, Sung Hee;
    • Takeuchi, Madoka;
    • Skali, Hicham;
    • Desai, Akshay S.;
    • Køber, Lars;
    • Maggioni, Aldo P.;
    • Rouleau, Jean L.;
    • Kelly, Roxzana Y.;
    • Hester, Allen;
    • Keefe, Deborah;
    • McMurray, John J. V.;
    • Pfeffer, Marc A.;
    • Solomon, Scott D.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21

    Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) programme.

    Published in:
    European Journal of Heart Failure, 2010, v. 12, n. 7, p. 738, doi. 10.1093/eurjhf/hfq065
    By:
    • Su Min Chang;
    • Granger, Christopher B.;
    • Johansson, Peter A.;
    • Kosolcharoen, Peter;
    • McMurray, John J. V.;
    • Michelson, Eric L.;
    • Murray, David R.;
    • Olofsson, Bertil;
    • Pfeffer, Marc A.;
    • Solomon, Scott D.;
    • Swedberg, Karl;
    • Yusuf, Salim;
    • Dunlap, Mark E.
    Publication type:
    Article
    22
    23
    24

    Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity–mortality trial.

    Published in:
    European Journal of Heart Failure, 2009, v. 11, n. 8, p. 795, doi. 10.1093/eurjhf/hfp098
    By:
    • McMurray, John J. V.;
    • Anand, Inder S.;
    • Diaz, Rafael;
    • Maggioni, Aldo P.;
    • O'Connor, Christopher;
    • Pfeffer, Marc A.;
    • Polu, Krishna R.;
    • Solomon, Scott D.;
    • Yan Sun;
    • Swedberg, Karl;
    • Tendera, Michal;
    • Van Veldhuisen, Dirk J.;
    • Wasserman, Scott M.;
    • Young, James B.
    Publication type:
    Article
    25

    Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

    Published in:
    2009
    By:
    • Hawkins NM;
    • Huang Z;
    • Pieper KS;
    • Solomon SD;
    • Kober L;
    • Velazquez EJ;
    • Swedberg K;
    • Pfeffer MA;
    • McMurray JJ;
    • Maggioni AP;
    • Valsartan in Acute Myocardial Infarction Trial Investigators;
    • Hawkins, Nathaniel M;
    • Huang, Zhen;
    • Pieper, Karen S;
    • Solomon, Scott D;
    • Kober, Lars;
    • Velazquez, Eric J;
    • Swedberg, Karl;
    • Pfeffer, Marc A;
    • McMurray, John J V
    Publication type:
    journal article
    26

    Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

    Published in:
    European Journal of Heart Failure, 2009, v. 11, n. 3, p. 292, doi. 10.1093/eurjhf/hfp001
    By:
    • Hawkins, Nathaniel M.;
    • Zhen Huang;
    • Pieper, Karen S.;
    • Solomon, Scott D.;
    • Kober, Lars;
    • Velazquez, Eric J.;
    • Swedberg, Karl;
    • Pfeffer, Marc A.;
    • McMurray, John J. V.;
    • Maggioni, Aldo P.
    Publication type:
    Article
    27

    Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker.: Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial

    Published in:
    European Journal of Heart Failure, 2008, v. 10, n. 2, p. 157, doi. 10.1016/j.ejheart.2007.12.006
    By:
    • Weir, R.A.P.;
    • McMurray, John J.V.;
    • Puu, Margareta;
    • Solomon, Scott D.;
    • Olofsson, Bertil;
    • Granger, Christopher B.;
    • Yusuf, Salim;
    • Michelson, Eric L.;
    • Swedberg, Karl;
    • Pfeffer, Marc A.
    Publication type:
    Article
    28

    Previously known and newly diagnosed atrial fibrillation: A major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction

    Published in:
    European Journal of Heart Failure, 2006, v. 8, n. 6, p. 591, doi. 10.1016/j.ejheart.2005.11.007
    By:
    • Køber, Lars;
    • Swedberg, Karl;
    • McMurray, John J.V.;
    • Pfeffer, Marc A.;
    • Velazquez, Eric J.;
    • Diaz, Rafael;
    • Maggioni, Aldo P.;
    • Mareev, Viatcheslav;
    • Opolski, Grzegorz;
    • Van de Werf, Frans;
    • Zannad, Faiez;
    • Ertl, Georg;
    • Solomon, Scott D.;
    • Zelenkofske, Steven;
    • Rouleau, Jean-Lucien;
    • Leimberger, Jeffrey D.;
    • Califf, Robert M.
    Publication type:
    Article
    29
    30

    Site selection for heart failure clinical trials in the USA.

    Published in:
    Heart Failure Reviews, 2015, v. 20, n. 4, p. 375, doi. 10.1007/s10741-015-9473-z
    By:
    • Harinstein, Matthew;
    • Butler, Javed;
    • Greene, Stephen;
    • Fonarow, Gregg;
    • Stockbridge, Norman;
    • O'Connor, Christopher;
    • Pfeffer, Marc;
    • Mehra, Mandeep;
    • Solomon, Scott;
    • Yancy, Clyde;
    • Fiuzat, Mona;
    • Mentz, Robert;
    • Collins, Sean;
    • McMurray, John;
    • Vaduganathan, Muthiah;
    • Dunnmon, Preston;
    • Rosano, Giuseppe;
    • Dinh, Wilfried;
    • Misselwitz, Frank;
    • Bonow, Robert
    Publication type:
    Article
    31
    32
    33
    34
    35
    36

    Effects of high‐dose versus standard‐dose quadrivalent influenza vaccine among patients with diabetes: A post‐hoc analysis of the DANFLU‐1 trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 5, p. 1821, doi. 10.1111/dom.15498
    By:
    • Lassen, Mats C. Højbjerg;
    • Johansen, Niklas Dyrby;
    • Modin, Daniel;
    • Nealon, Joshua;
    • Samson, Sandrine;
    • Dufournet, Marine;
    • Loiacono, Matthew M.;
    • Larsen, Carsten Schade;
    • Jensen, Anne Marie Reimer;
    • Landler, Nino Emanuel;
    • Claggett, Brian L.;
    • Solomon, Scott D.;
    • Landray, Martin J.;
    • Gislason, Gunnar H.;
    • Køber, Lars;
    • Jensen, Jens Ulrik Stæhr;
    • Sivapalan, Pradeesh;
    • Vestergaard, Lasse Skafte;
    • Krause, Tyra Grove;
    • Biering‐Sørensen, Tor
    Publication type:
    Article
    37
    38

    Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3327, doi. 10.1111/dom.15232
    By:
    • Heerspink, Hiddo J. L.;
    • Vart, Priya;
    • Jongs, Niels;
    • Neuen, Brendon L.;
    • Bakris, George;
    • Claggett, Brian;
    • Vaduganathan, Muthiah;
    • McCausland, Finnian;
    • Docherty, Kieran F.;
    • Jhund, Pardeep S.;
    • Solomon, Scott D.;
    • Perkovic, Vlado;
    • McMurray, John J. V.
    Publication type:
    Article
    39
    40

    Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1199, doi. 10.1111/dom.13642
    By:
    • Charytan, David M.;
    • Solomon, Scott D.;
    • Ivanovich, Peter;
    • Remuzzi, Giuseppe;
    • Cooper, Mark E.;
    • McGill, Janet B.;
    • Parving, Hans‐Henrik;
    • Parfrey, Patrick;
    • Singh, Ajay K.;
    • Burdmann, Emmanuel A.;
    • Levey, Andrew S.;
    • Eckardt, Kai‐Uwe;
    • McMurray, John J.V.;
    • Weinrauch, Larry A.;
    • Liu, Jiankang;
    • Claggett, Brian;
    • Lewis, Eldrin F.;
    • Pfeffer, Marc A.
    Publication type:
    Article
    41

    Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic Diseases: A Randomized Clinical Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2024, v. 332, n. 22, p. 1900, doi. 10.1001/jama.2024.21060
    By:
    • Johansen, Niklas Dyrby;
    • Vaduganathan, Muthiah;
    • Bhatt, Ankeet S.;
    • Modin, Daniel;
    • Chatur, Safia;
    • Claggett, Brian L.;
    • Janstrup, Kira Hyldekær;
    • Larsen, Carsten Schade;
    • Larsen, Lykke;
    • Wiese, Lothar;
    • Dalager-Pedersen, Michael;
    • Køber, Lars;
    • Solomon, Scott D.;
    • Sivapalan, Pradeesh;
    • Jensen, Jens Ulrik Stæhr;
    • Martel, Cyril Jean-Marie;
    • Krause, Tyra Grove;
    • Biering-Sørensen, Tor
    Publication type:
    Article
    42
    43

    Cardiovascular Burden of the V142I Transthyretin Variant.

    Published in:
    JAMA: Journal of the American Medical Association, 2024, v. 331, n. 21, p. 1824, doi. 10.1001/jama.2024.4467
    By:
    • Selvaraj, Senthil;
    • Claggett, Brian;
    • Shah, Svati H.;
    • Mentz, Robert J.;
    • Khouri, Michel G.;
    • Manichaikul, Ani W.;
    • Khan, Sadiya S.;
    • Rich, Stephen S.;
    • Mosley, Thomas H.;
    • Levitan, Emily B.;
    • Arora, Pankaj;
    • Goyal, Parag;
    • Haring, Bernhard;
    • Eaton, Charles B.;
    • Cheng, Richard K.;
    • Wells, Gretchen L.;
    • Manson, JoAnn E.;
    • Fontana, Marianna;
    • Solomon, Scott D.
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50